Analysis about stemness and pathophysiology of pancreatic cancer stem cells expressing calreticulin
| Project/Area Number |
18K16365
|
|---|
| Research Category |
Grant-in-Aid for Early-Career Scientists
|
| Allocation Type | Multi-year Fund |
|---|
| Review Section |
Basic Section 55020:Digestive surgery-related
|
|---|
| Research Institution | Yamaguchi University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2018-04-01 – 2020-03-31
|
| Project Status |
Completed (Fiscal Year 2019)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2019: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2018: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | 膵癌幹細胞 / Calreticulin / 癌幹細胞性 / 免疫逃避機構 / 癌幹細胞 / 膵癌 |
|---|
| Outline of Final Research Achievements |
Panc-1 Lm, a pancreatic cancer stem-like cell enriched population induced from the pancreatic cancer cell line Panc-1, has a high proportion of side population showing an increased ABC transporter activity as a mechanism of drug resistance, and has a sphere-forming ability. These results implied that Panc-1 Lm has cancer stem cell properties. And, their high expression of PD-L1, which is an immune checkpoint-related molecule, and reduced expression of HLA class I molecule could be a mechanism of evasion from the immune surveillance. Moreover, Calreticulin-positive cells contained in the induced cells had higher sphere-forming ability and immune escape mechanism by surface antigens.
|
| Academic Significance and Societal Importance of the Research Achievements |
本研究を通して、我々が独自の方法で、膵癌細胞株から誘導した膵癌幹細胞様細胞が豊富な細胞集団の癌幹細胞性が確認できた。さらに、この細胞は免疫チェックポイント関連分子を発現し、HLA class I分子の発現を低下させることで、免疫監視機構から逃避している可能性が示唆された。今後、表面抗原のみならず免疫逃避に関連する液性因子の発現の解析、免疫担当細胞との共培養実験を通して、癌幹細胞の免疫逃避機構を解明することで、癌の新たな治療法開発を目指している。
|
Report
(3 results)
Research Products
(1 results)
